Details of the Drug
General Information of Drug (ID: DMOLFHZ)
| Drug Name |
4-cyanophenylboronic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-Cyanophenylboronic acid; 126747-14-6; (4-cyanophenyl)boronic Acid; 4-Cyanobenzeneboronic Acid; 4-cyanophenyl boronic acid; 4-cyano-phenyl-boronic acid; 4-Boronobenzonitrile; 4-(dihydroxyboranyl)benzonitrile; p-cyanophenylboronic acid; 4-cyanobenzene boronic acid; (4-cyano-phenyl)boronic acid; CEBAHYWORUOILU-UHFFFAOYSA-N; MFCD01318968; BORONIC ACID, (4-CYANOPHENYL)-; 4-Cyanophenylboronic acid, 97%; ACMC-209bbp; AC1MC0VB; 4-cyanoplienylboronic acid; 4-cyano phenylboronic acid; 4-cyano-phenylboronic acid; 4-cyanophenyl-boronic
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 146.94 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


